Skip to main content
logo
Lantheus Holdings, Inc. (LNTH)
NASDAQ: LNTH · Real-Time Price · USD
83.22
+3.21 (4.01%)
At close: Mar 10, 2026, 4:00 PM EDT
82.68
-0.54 (-0.65%)
Pre-market: Mar 11, 2026, 8:33 AM EDT

Revenue Breakdown

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
PYLARIFY Revenue
989.12M1.06B
PYLARIFY Revenue Growth
-6.50%24.26%
Other Radiopharmaceutical Oncology Revenue
-384.00K
Other Radiopharmaceutical Oncology Revenue Growth
--87.73%
Total Radiopharmaceutical Oncology Revenue
989.12M1.06B
Total Radiopharmaceutical Oncology Revenue Growth
-6.53%23.85%
DEFINITY Revenue
330.25M317.79M
DEFINITY Revenue Growth
3.92%13.59%
Neuraceq Revenue
51.45M-
TechneLite Revenue
86.80M95.49M
TechneLite Revenue Growth
-9.09%9.29%
Other Precision Diagnostics Revenue
24.62M24.23M
Other Precision Diagnostics Revenue Growth
1.59%5.44%
Total Precision Diagnostics Revenue
493.11M437.51M
Total Precision Diagnostics Revenue Growth
12.71%12.15%
Strategic Partnerships and Other Revenue
59.38M38.18M
Strategic Partnerships and Other Revenue Growth
55.52%-26.40%
Revenue (Total)
1.54B1.53B
Revenue (Total) Growth
0.50%18.32%

Revenue Breakdown 2

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Product Revenue
1.51B1.52B
Product Revenue Growth
-1.13%20.72%
License and Royalty Revenue
34.04M9.13M
License and Royalty Revenue Growth
272.88%-72.64%
Revenue (Total)
1.54B1.53B
Revenue (Total) Growth
0.50%18.32%
Updated Feb 26, 2026. Data Source: Fiscal.ai.